By Ernie Mundell HealthDay ReporterTHURSDAY, July 31, 2025 (HealthDay News) — There’s potentially exciting news from a trial ...

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

Receiving treatment within the first month of life could protect children for at least three years, a study suggests.

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...

The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.

Plasma samples showed an association between suppressed extracellular vesicles and an increased risk for liver cancer.

A new study in Nature shows that delivering a single injection of gene therapy at birth may offer years-long protection ...

Decisions from the U.S. Preventative Services Task Force impact millions of people’s access to preventative care for cancer, ...

Quality of life in people living with HIV was lower in those who had weight gain from adherence to antiretroviral therapy.

The temporary loss of key HIV grants forced organizations to cut hours, furlough workers and delay critical public health initiatives.